Summary Information:
PTC Therapeutics Inc. Common Stock
NASDAQ:PTCT


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


PTC Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: PTCT
SEC CIK: 0001070081
Phone: 9082227000
100 CORPORATE COURT
SOUTH PLAINFIELD NJ 07080-2449

CEO: Stuart Peltz
Price when page updated: 23.25 Date: 2023-12-01
Company Website:
www.ptcbio.com

_Description: PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and its mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.

IPO YEAR:
2013
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
1754518121.00
Beta:
0.716844309736283
52 Week High:
68.85
52 Week Low:
34.85
52 Week Change:
-0.3612206161483428
Short Interest:

Short Date:

Shares Outstanding:
70697900
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
27 Oct 2022
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$304.40
ttmEPS:
-6.5
Revenue:
$618.233M
Gross Profit:

Cash:

Debt:

Institution Percent:
-
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.30%
Return on Assets:
-29.40%
Return on Capital:

Profit Margin:
-89.90%
Price to Sales:
5.35
Price To Book:
-
Short Ratio:
8.19
PE Ratio:
-6.798024407129828
Employees:
963
1Y Guesstimate
58.857:1.0:4




__The following are links to various summary and news pages for
__PTC Therapeutics Inc. Common Stock [ PTCT ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01